Uncategorised - European Medical Journal

Interview: Christopher Tomassian

Christopher Tomassian. Founder/CEO, The Dermatology Collective, Glendora, California, USA.

Physician and medical team providing urgent care to an elderly patient in a modern hospital ward ICU.

Overlooked Respiratory Virus Putting Hematology Patients at Risk

A new registry study reveals human metapneumovirus causes severe illness in blood cancer patients worldwide.

Atrial Fibrillation Treatment: Devices vs Anticoagulants

Non–procedure-related bleeding occurred in 10.9% of patients receiving left atrial appendage closure versus 19.0% of those on anticoagulants (hazard ratio: 0.55; 95% CI: 0.45–0.67; p

Total Working Hours Linked to Poor Sleep and Mental Health

Long total working hours, including unpaid care, affect sleep quality and mental health, especially in middle-aged women.

The Silent Pandemic: Modelling the Future of AMR

How can data reveal the hidden pathways of antimicrobial resistance? The EMJ Podcast continues its special AMR series, The Silent Pandemic.

Higher BMI May Protect Against Cardiovascular Events in CKD

A new study suggests that sustained higher BMI may reduce cardiovascular risk in chronic kidney disease, challenging traditional weight management approaches.

diabetes COVID

Prevalence of Incident Diabetes Increases After COVID-19 Infection

The prevalence of incident diabetes increases following COVID-19 infection, a 2026 systematic review and meta-analysis has revealed.

Diet-Linked Metabolites May Influence Knee Osteoarthritis Risk

A study finds metabolomic signatures linked to healthy diets may reduce knee osteoarthritis risk, with BMI mediating much of the association.

Fibre Could Boost Recovery in Coeliac Disease

New research reveals impaired fibre metabolism in celiac disease. Fibre supplementation may support gut microbiota and enhance gut healing.

Lifestyle Interventions Effective in Prostate Cancer Radiotherapy

Nutrition and lifestyle interventions are promising for improving the quality of life of patients with prostate cancer undergoing radiotherapy, a 2026 review has concluded.